Preclinical Evidence for Therapeutic Efficacy of Selective Estrogen receptor Modulators for Uterine Leiomyoma-Reference-Cited by-同舟云学术

Preclinical Evidence for Therapeutic Efficacy of Selective Estrogen receptor Modulators for Uterine Leiomyoma

Published:2000-07 Issue:4 Volume:7 Page:249-256
ISSN:1071-5576
Container-title:Journal of the Society for Gynecologic Investigation
language:en
Short-container-title:Journal of the Society for Gynecologic Investigation

Author:

Walker Cheryl Lyn¹,Burroughs Kevin D.,Davis Barbara,Sowell Kalyn,Everitt Jeffrey I.,Fuchs-Young Robin²

Affiliation:

1. University of Texas M. D. Anderson Cancer Center-Science Park, research Division, Smithville, Texas; the national Institute of Environmental Health Sciences, Research Triangle Park, North Carolina; Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina;

2. University of Texas M. D. Anderson Cancer Center-Science Park, research Division, Smithville, Texas; the national Institute of Environmental Health Sciences, Research Triangle Park, North Carolina; Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/107155760000700410

Reference37 articles.

1. The Frequency of Uterine Leiomyomas

2. Uterine leiomyomata: etiology, symptomatology, and management

3. Epidemiology of Myomas

4. Therapeutic Uses of Gonadotropin-Releasing Hormone Analogs

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Off-Label use of Raloxifene hydrochloride in uterine fibroids: A novel insert-based formulation approach and IN-VIVO preclinical evaluation;Journal of Drug Delivery Science and Technology;2023-06

2. Understanding main pregnancy complications through animal models;Journal of Reproductive Immunology;2022-09

3. Uterine Leiomyomas;Clinical Reproductive Medicine and Surgery;2022

4. Benign Uterine Diseases;Yen and Jaffe's Reproductive Endocrinology;2019

5. Uterine Mesenchymal Tumors;Diagnostic Gynecologic and Obstetric Pathology;2018